当前位置：Public Access >页面
Chinese/English
Camrellizumab combined with stereotactic radiotherapy, apatinib mesylate and albumin-conjugated paclitaxel for the first-line treatment of patients with locally advanced or metastatic non-small cell lung cancer with non-sensitive gene mutations: a prospective, single arm, single center, exploratory clinical study
Filter Options
Patient No. Patient Name Patient Gender
Sitting Education Date of enrollment FromTo
       More Options
Patient No Gender Date of enrollment Sitting Creater Operate
004 Man 2025-07-29

In hospital

 marina052 view data
003 Man 2025-09-08

In hospital

 marina052 view data
002 Man 2020-03-22

In hospital

 陌上新桑 view data
001 Man 2019-10-16

In hospital

 陌上新桑 view data

提示：推荐使用chrome浏览器 并且在宽屏显示分辨率下使用系统。

Copyright(c) (2010-2013) .All rights reserved.临床试验公共管理平台 版权所有